NCT00004800View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

PHASE3CompletedINTERVENTIONAL

Enrollment

13,250

Participants

Timeline

Start Date

September 30, 1992

Conditions

Pertussis

Interventions

BIOLOGICAL

diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis

BIOLOGICAL

diphtheria-tetanus vaccine

All Listed Sponsors

collaborator

Istituto Superiore di Sanità

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00004800 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines | Biotech Hunter | Biotech Hunter